Literature DB >> 26673227

Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry.

Takayo Murase1, Mai Nampei2, Mitsuru Oka3, Naoki Ashizawa4, Koji Matsumoto4, Atsushi Miyachi5, Takashi Nakamura2.   

Abstract

Studies of pathological mechanisms and XOR inhibitor characterization, such as allopurinol, febuxostat, and topiroxostat, require accurate and sensitive measurements of XOR activity. However, the established assays have some disadvantages such as susceptibility to endogenous substances such as uric acid (UA), xanthine, or hypoxanthine. Here, we aimed to develop a novel XOR activity assay utilizing a combination of high-performance liquid chromatography (LC) and high-resolution mass spectrometry (HRMS) for tissues such as the liver, kidney, and plasma. Stable isotope-labeled [(15)N2]-xanthine was utilized as substrate and the production of [(15)N2]-uric acid was determined. [(15)N2]-UA production by XOR was dependent on the amounts of [(15)N2]-xanthine and enzyme and the time of reaction. Because high concentrations of endogenous xanthine and hypoxanthine affect XOR activities, we employed a multi-component analysis using LC/HRMS to improve the accuracy of XOR activity assay. Quantification of [(15)N2]-UA was validated and showed good linearity, accuracy, and precision. We measured the XOR activities of retired ICR mice using [(15)N2]-xanthine and LC/MS. The XOR activities in plasma, kidney, and liver samples were 38.1±0.7, 158±5, 928±25pmol/min/mg of protein, respectively (mean±SD, n=5). Furthermore, we measured the XOR activities in the same samples using the LC/ultraviolet and LC/fluorescence (FL) methods. The level of [(15)N2]-xanthine oxidation by XOR was equal to that of xanthine oxidation and approximately 7.9-8.9 times higher than that of pterin oxidation. We found a good correlation between XOR activities examined using LC/MS assay with [(15)N2]-xanthine and those examined using LC/FL assay with pterin. This result suggested that although both the LC/MS assay with [(15)N2]-xanthine and the LC/FL assay with pterin were useful, the former provided information regarding XOR activities that more directly reflected the physiological condition than the latter.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  High-resolution mass spectrometry; Stable isotope-labeled substrate; Xanthine oxidoreductase activity; Xanthine oxidoreductase inhibitor

Mesh:

Substances:

Year:  2015        PMID: 26673227     DOI: 10.1016/j.jchromb.2015.11.030

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

1.  Xanthine oxidoreductase activity is correlated with hepatic steatosis.

Authors:  Chisako Yagi; Yoshiki Kusunoki; Taku Tsunoda; Takayo Murase; Takashi Nakamura; Keiko Osugi; Mana Ohigashi; Akiko Morimoto; Akio Miyoshi; Miki Kakutani-Hatayama; Kae Kosaka-Hamamoto; Manabu Kadoya; Kosuke Konishi; Takuhito Shoji; Hidenori Koyama
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

2.  Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice.

Authors:  Seiji Itano; Hiroyuki Kadoya; Minoru Satoh; Takashi Nakamura; Takayo Murase; Tamaki Sasaki; Yashpal S Kanwar; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-21

3.  Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.

Authors:  Ayumi Nakatani; Shinya Nakatani; Eiji Ishimura; Takayo Murase; Takashi Nakamura; Mari Sakura; Yu Tateishi; Akihiro Tsuda; Masafumi Kurajoh; Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

4.  Plasma xanthine oxidoreductase activity in patients with decompensated acute heart failure requiring intensive care.

Authors:  Hirotake Okazaki; Akihiro Shirakabe; Masato Matsushita; Yusaku Shibata; Tomofumi Sawatani; Saori Uchiyama; Kennichi Tani; Takayo Murase; Takashi Nakamura; Tsutomu Takayasu; Miwako Asano; Nobuaki Kobayashi; Noritake Hata; Kuniya Asai; Wataru Shimizu
Journal:  ESC Heart Fail       Date:  2019-01-08

5.  Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy.

Authors:  Takeo Ishii; Tomohiro Kumagae; Hiromichi Wakui; Shingo Urate; Shohei Tanaka; Eriko Abe; Toru Suzuki; Takahiro Yamaji; Sho Kinguchi; Ryu Kobayashi; Kotaro Haruhara; Takashi Nakamura; Shuzo Kobayashi; Kouichi Tamura
Journal:  FEBS Open Bio       Date:  2021-02-01       Impact factor: 2.792

6.  Teneligliptin Decreases Uric Acid Levels by Reducing Xanthine Dehydrogenase Expression in White Adipose Tissue of Male Wistar Rats.

Authors:  Chihiro Moriya; Hiroaki Satoh
Journal:  J Diabetes Res       Date:  2016-08-29       Impact factor: 4.011

7.  Habitual exercise decreases plasma xanthine oxidoreductase activity in middle-aged and older women.

Authors:  Keisei Kosaki; Atsuko Kamijo-Ikemori; Takeshi Sugaya; Koichiro Tanahashi; Nobuhiko Akazawa; Chihiro Hibi; Takashi Nakamura; Takayo Murase; Kenjiro Kimura; Yugo Shibagaki; Seiji Maeda
Journal:  J Clin Biochem Nutr       Date:  2018-03-30       Impact factor: 3.114

8.  Hydrogen Gas Inhalation Attenuates Endothelial Glycocalyx Damage and Stabilizes Hemodynamics in a Rat Hemorrhagic Shock Model.

Authors:  Tomoyoshi Tamura; Motoaki Sano; Tadashi Matsuoka; Joe Yoshizawa; Ryo Yamamoto; Yoshinori Katsumata; Jin Endo; Koichiro Homma; Mayumi Kajimura; Masaru Suzuki; Eiji Kobayashi; Junichi Sasaki
Journal:  Shock       Date:  2020-09       Impact factor: 3.533

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.